Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Šterclová (Prague, Czech Republic), M. PetrEk (Olomouc, Czech Republic), A. Kishore (Olomouc, Czech Republic), J. Skibova (Prague, Czech Republic), M. Vasakova (Prague, Czech Republic). Effect of genotype on hypersensitivity pneumonitis despite treatment.. 3665

Member's Comments

No comment yet.

Related content which might interest you: The effects of oral corticosteroid treatment (OCS) on sequential lung function tests in a cohort of patients with acute hypersensitivity pneumonitis (AHP) Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children Year: 2020 Consort hypersensitivity pneumonitis Source: Eur Respir J 2009; 33: 1223-1225 Year: 2009 Diagnosis, course and management of hypersensitivity pneumonitis Source: Eur Respir Rev, 31 (163) 210169; 10.1183/16000617.0169-2021 Year: 2022 Squeaks in hypersensitivity pneumonitis: prevalence and clinical correlates Source: International Congress 2019 – Pathogenesis and prognosis of interstitial lung disease of known origin Year: 2019 Immunomodulatory treatment of severe persistent asthma with interferon-αcon-1 (IFN-αcon-1). Effect on the clinical course of oral corticosteroid dose and eosinophil numbers Source: Annual Congress 2003 - Modulation of bronchial hyperreactivity and immune response in the airways Year: 2003 Hypersensitivity pneumonitis associated with the use of temozolomide Source: Eur Respir J 2009; 33: 931-934 Year: 2009 Hypersensitivity pneumonitis: current concepts Source: Eur Respir J 2001; 18: 81S-92S Year: 2001 Treatment of hypersensitivity pneumonitis (HP) - targeting pathways of inflammation and fibrosis Source: International Congress 2017 – Hypersensitivity pneumonitis: current concepts and perspectives in diagnosis, pathogenesis and management Year: 2017 Characterisation of patients with chronic hypersensitivity pneumonitis (CHP) - a seven year single centre experience Source: Virtual Congress 2020 – Clinical issues in granulomatous lung diseases Year: 2020 Prognostic characteristics in chronic hypersensitivity pneumonitis. Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Age at diagnosis and degree of pulmonary function tests disturbances in hypersensitivity pneumonitis (HP) patients Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010 Osimertinib rechallenge under steroid protection following osimertinib-induced pneumonitis: Three case studies. Source: Virtual Congress 2021 – COVID-19 and management of lung cancer Year: 2021 Pigeon breeder‘s hypersensitivity pneumonitis – possible antigen exposure reduction after diagnosis in the most susceptible patients Source: Annual Congress 2009 - High molecular sensitisers and biological dusts Year: 2009 Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitis Source: ERJ Open Res, 3 (3) 00016-2017; 10.1183/23120541.00016-2017 Year: 2017 Serious infections in sarcoidosis and the effect of treatment Source: International Congress 2019 – Granulomatous disorders: from bench to bedside Year: 2019 Importance of unrecognised exposure to avian antigen in chronic bird-related hypersensitivity pneumonitis Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009 Effects of treatment with angiotensin-(1-7) on antigen sensitization of murine experimental model of asthma Source: International Congress 2019 – Modelling and monitoring of airway diseases Year: 2019 Factors predicting response to azathioprine in chronic hypersensitivity pneumonitis – the importance of BAL lymphocytosis Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment Year: 2018 Mechanisms of exercise limitation in patients with chronic hypersensitivity pneumonitis Source: ERJ Open Res, 4 (3) 00043-2018; 10.1183/23120541.00043-2018 Year: 2018 Impact of BAL lymphocytosis and presence of honeycombing on corticosteroid treatment effect in fibrotic hypersensitivity pneumonitis: a retrospective cohort study Source: Eur Respir J, 55 (4) 1901983; 10.1183/13993003.01983-2019 Year: 2020